// COMPANY
Hatteras Venture Partners
SECTOR VENTURE CAPITALMENTIONS 4LAST SEEN NOVEMBER 3, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
4 SIGNALS
01
funding·PitchBook News·NOVEMBER 3, 2026
“Specific Biologics... which develops gene-editing therapies for genetic diseases, raised a $35 million Series A led by Hatteras Venture Partners.”
Source→02
funding·StrictlyVC·OCTOBER 16, 2026
Source→03
hire·Axios Pro Rata·OCTOBER 1, 2026
“joined Hatteras Venture Partners as chairman.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.